Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma, a real-world analysis
Clinical Lymphoma Myeloma and Leukemia（2022）
摘要
The MASS system is a reliable risk stratification tool for patients with NDMM in real-world clinical practice.
更多查看译文
关键词
Mayo Additive Staging System,multiple myeloma,overall survival,progression-free survival,risk stratification
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要